← Back to Search

Behavioural Intervention

Active iTBS for Alcoholism

N/A
Waitlist Available
Led By Timothy C Durazzo, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will study whether a type of brain stimulation called intermittent theta burst repetitive transcranial magnetic stimulation (iTBS) can help decrease the high rate of relapse among Veterans with alcohol use disorder (AUD). iTBS has been shown to be as effective and safe as another type of brain stimulation called repetitive transcranial magnetic stimulation (rTMS) in treating depressive disorders. The advantage of iTBS is that it can be delivered in a shorter amount of time. It is hypothesized that Veterans with AUD who receive active iTBS will show significant decreases in alcohol craving, depressive symptomatology, and cigarette consumption, as well as improved neuroc

Eligible Conditions
  • Alcoholism
  • Smoking/Cigarette Smoking
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants Who Were Abstinent Through Month 6
Secondary outcome measures
Anhedonic Depressive Symptoms
General Depressive Symptoms
Left Dorsolateral Prefrontal Cortex Thickness
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active iTBSActive Control1 Intervention
Participants will be randomized to active or sham iTBS.
Group II: Sham iTBSPlacebo Group1 Intervention
Participants will be randomized to active or sham iTBS.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,578 Total Patients Enrolled
12 Trials studying Alcoholism
2,245 Patients Enrolled for Alcoholism
Timothy C Durazzo, PhDPrincipal InvestigatorStanford University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025